ACPU
MACK

Arrowgrass Capital Partners (US)’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-29,085
Closed -$867K – 194
2013
Q3 		$867K Buy
+29,085
New +$867K 0.03% 134